1、 1 Bristol Myers Squibb Reports Third Quarter Financial Results for 2025 Performance Marked by Continued Growth Portfolio Momentum,Pipeline Advancements and Strategic Business Development Third quart。
2、Not for Product Promotional UseQ3 2025 ResultsOctober 30,2025Not for Product Promotional UseQ3 2025 ResultsForward Looking Statements and Non-GAAP Financial Information 2This presentation contains st。
3、UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549_FORM 10-Q_ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)OF THESECURITIES EXCHANGE ACT OF 1934For the quarterly period ended Sept。
4、 1 Bristol Myers Squibb Reports Second Quarter Financial Results for 2025 Performance Underscores Continued Execution Against Long-Term Growth Strategy Second quarter revenues were$12.3 billion Growt。
5、Not for Product Promotional UseQ2 2025 ResultsJuly 31,2025Not for Product Promotional UseQ2 2025 ResultsForward Looking Statements and Non-GAAP Financial Information 2This presentation contains state。
6、UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549_FORM 10-Q_ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)OF THESECURITIES EXCHANGE ACT OF 1934For the quarterly period ended June。
7、Bristol Myers Squibb2024 Financial ReportTable of ContentsManagements Discussion and 2 Analysis of Financial Condition and Results of OperationsQuantitative and Qualitative 35 Disclosures About Marke。
8、2024 ANNUAL REPORT 2025 Bristol-Myers Squibb Company.All rights reserved.In 2024,Bristol Myers Squibb marked the 10th anniversary of Global Patient Week,an event that connects employees with patients。
9、UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549_FORM 10-K_ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THESECURITIES EXCHANGE ACT OF 1934For the fiscal year ended December 31,。
10、UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549_FORM 10-Q_ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)OF THESECURITIES EXCHANGE ACT OF 1934For the quarterly period ended Marc。
11、 1 Bristol Myers Squibb Reports First Quarter Financial Results for 2025 Results Reflect Continued Growth Portfolio Momentum and Disciplined Execution First quarter revenues were$11.2 billion,-6%(-4%。
12、Not for Product Promotional UseQ1 2025 ResultsApril 24,2025Not for Product Promotional UseQ1 2025 ResultsForward Looking Statements and Non-GAAP Financial Information 2This presentation contains stat。
13、2023 Annual ReportOur MissionTo discover,develop and deliver innovative medicines that help patients prevail over serious diseasesOur VisionTo be the worlds leading biopharma company that transforms 。
14、UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549_FORM 10-K_ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THESECURITIES EXCHANGE ACT OF 1934For the fiscal year ended December 31,。
15、2022 Annual ReportOur MissionTo discover,develop and deliver innovative medicines that help patients prevail over serious diseasesOur VisionTo be the worlds leading biopharma company that transforms 。
16、此外,还不能保证仍在开发中的潜在药物或适应症会获得监管部门的批准。封面:我们布里斯班CA位点的一位早期发现研究者从工程细胞系中选择样本用于检测发展。我们相信科学的成功是由我们接触到的人来衡量的。因此,我们总是在努力,不断突破可能改变今天和明天生活的边界。。
17、2020 Annual ReportOur MissionTo discover,develop and deliver innovative medicines that help patients prevail over serious diseasesOur VisionTo be the worlds leading biopharma company that transforms 。
18、2 0 1 9 A N N U A L R E P O R TWere inspired by a single vision:The patient stories shared in this Annual Report depict individual patient responses to our medicines or investigational compounds and 。
19、|2018 ANNUAL REPORT|I WAS ALWAYS ACTIVE AND HEALTHY,AND NOW I FEEL GREAT,FINALLY LIKE MYSELF.“Carol Willis”The patient stories shared in this Annual Report depict individual patient responses to our 。
20、“KNOWING THERES A TEAM OF CARING EXPERTS GIVES ME HOPE AND LETS ME EMBRACE A LIFE NOT DEFINED BY MY DISEASE.”Mitra GhandeharizadehThe patient stories shared in this Annual Report depict individual pa。
21、 2016|Annual ReportIF I CAN LIVE MY LIFE AND INSPIRE OTHERS TO LIVE THEIR LIVES MORE FULLY,THEN IM BLESSED.”-Jeff Julian“The patient stories shared in this Annual Report depict individual patient res。
22、5asdBrenda Cushing,diagnosed with non-small cell lung cancer,is now being treated with an Immuno-Oncology therapy from Bristol-Myers Squibb.WORKING TOGETHER FOR PATIENTS2015|Annual Report345 Park Ave。
23、2014|Annual ReportDelivering Transformational Medicines to PatientsLOPQRusty Cline participated in a clinical trial for a new immunotherapy from Bristol-Myers Squibb.The patient stories shared in thi。
24、2013 Annual Report5asdEVOLVING TO A SPECIALTY CARE BIOPHARMA COMPANYDina Sienkiewicz,pictured here with her husband,Vinny,participated in an investigational clinical trial of the combination use of e。
25、2012 Annual ReportWe remain committed to a single overriding mission:to help more patients prevail in their fight against serious diseases.On the COver Eliquis the SCientifiC JOurneyThe scientific jo。
26、2011 ANNUAL REPORTInnovationInnovationgrowth throughYervoy patient and flight paramedic Bobby HarshOn the Cover:Yervoy(ipilimumab)patient and flight paramedic Yervoy(ipilimumab)patient and flight par。
27、Bristol-Myers Squibb345 Park Avenue New York,NY 10154-0037 212-546-4000 Get the free mobile app at http:/gettag.mobi2010 ANNUAL REPORTOUR BIOPHARMA TRANSFORMATIONSignificant Changes.Significant Resul。
28、2009 ANNUAL REPORTDELIVERING ON OUR COMMITMENTSBristol-Myers Squibb345 Park Avenue New York,NY 10154-0037 212-546-4000 This QR-Code can be read with most standard Smartphone QR-Code Reader Apps.ACME-。
29、5asdBioPharma:our Strategy in action2008 annual reporton left:Zhen Jin,a research scientist at KAI Pharmaceuticals in South San Francisco,compares tissue samples as part of a cardio-vascular disease 。
30、bio pharmaNOPQ2007 Annual Reportbio pharmathenextgenerationNOPQTogether we can prevail.TM345 Park Avenue|New York,NY 10154-0037|212-546-4000|Building bridgesAll too often,patients worldwideface barri。
31、NOPQTheir will.Our medicines.Together we can prevail.2006 Annual Report Our companys mission is to extend and enhance human lifeby providing the highest-quality pharmaceutical and relatedhealth care 。
32、Every hour.Everywhere.A day in the life of Bristol-Myers SquibbLOPQ2005 Annual ReportOn the coverHomestead,FloridaWhen Dixie Dixon was born,doctors learned that she had a hole in her heart.Dixies ped。
33、Bristol-Myers Squibb Company 2004 Annual ReportI hope that my experience can INSPIRE other patients to KEEP GOING.“”Breast cancer patient Julia Maason the coverThe Bristol-Myers Squibb MissionOur com。
34、2021 Environmental,Social and Governance ReportProgress against 16+indicators in accordance with the BioPharma Alliance,SASB and GRITable of Contents 3 About Bristol Myers Squibb 9 Ethics,Integrity,Q。
35、Bristol-Myers Squibb Company2003 Annual ReportFOCUSNOPQR345 Park AvenueNew York,NY 10154-0037Telephone:212-546-The Bristol-Myers Squibb MissionOur companys mission is to extend and enhance human life。